Fig. 3: Proportional classification of samples by array design. | npj Genomic Medicine

Fig. 3: Proportional classification of samples by array design.

From: Exon-focused targeted oligonucleotide microarray design increases detection of clinically relevant variants across multiple NHS genomic centres

Fig. 3

a Traditional oligo-array design (CytoSure v2)—number of CNVs identified (percentage of total) in each classification bin (Benign, Likely Benign, VOUS, Likely Pathogenic and Pathogenic) and reporting rate. b Oligo-array CGH with enhanced exon-level coverage of genes identified as being important in developmental disorders from research projects (CytoSure v3)—number of samples (percentage of total) classed as Benign, Likely Benign, VOUS, Likely Pathogenic or Pathogenic and reporting rate.

Back to article page